Choi HM, Yoon YE, Oh IY, Cho Y, Cho GY Global Left Atrial Strain as a Predictor of Silent Atrial Fibrillation Following Dual Chamber Cardiac Implantable Electronic Device Implantation. JACC Cardiovasc Imaging. 2018 Oct;11(10):1537-1539. doi: 10.1016/j.jc
Gan GCH, Ferkh A, Boyd A, Thomas L Left atrial function: evaluation by strain analysis. Cardiovasc Diagn Ther. 2018 Feb;8(1):29-46. doi: 10.21037/cdt.2017.06.08.
Guo C, Liu J, Zhao S, Teng Y, Shen L Decreased left atrial strain parameters are correlated with prolonged total atrial conduction time in lone atrial fibrillation. Int J Cardiovasc Imaging. 2016 Jul;32(7):1053-61. doi: 10.1007/s10554-016-0875-3. Epub 20
Jarasunas J, Aidietis A, Aidietiene S Left atrial strain - an early marker of left ventricular diastolic dysfunction in patients with hypertension and paroxysmal atrial fibrillation. Cardiovasc Ultrasound. 2018 Oct 31;16(1):29. doi: 10.1186/s12947-018-01
Park JJ, Park JH, Hwang IC, Park JB, Cho GY, Marwick TH Left Atrial Strain as a Predictor of New-Onset Atrial Fibrillation in Patients With Heart Failure. JACC Cardiovasc Imaging. 2020 Oct;13(10):2071-2081. doi: 10.1016/j.jcmg.2020.04.031. Epub 2020 Jul
Shin DG, Kang MK, Han D, Choi S, Cho JR, Lee N Enlarged left atrium and decreased left atrial strain are associated with atrial fibrillation in patients with hyperthyroidism irrespective of conventional risk factors. Int J Cardiovasc Imaging. 2022 Mar;38
Can Left Atrial Strain Measurements, and Correlating Changes in Left Atrium Area and Volume Size, be Used as an Early Predictor of Atrial Fibrillation?
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.